L. HANOĞLU Et Al. , "FDG-PET scanning shows distributed changes in cortical activity associated with visual hallucinations in eye disease," Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.19, no.1, pp.84-89, 2019
HANOĞLU, L. Et Al. 2019. FDG-PET scanning shows distributed changes in cortical activity associated with visual hallucinations in eye disease. Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.19, no.1 , 84-89.
HANOĞLU, L., YILDIZ, S., ÇAKIR, T., Hanoglu, T., & Yulug, B., (2019). FDG-PET scanning shows distributed changes in cortical activity associated with visual hallucinations in eye disease. Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.19, no.1, 84-89.
HANOĞLU, Lütfü Et Al. "FDG-PET scanning shows distributed changes in cortical activity associated with visual hallucinations in eye disease," Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.19, no.1, 84-89, 2019
HANOĞLU, Lütfü Et Al. "FDG-PET scanning shows distributed changes in cortical activity associated with visual hallucinations in eye disease." Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.19, no.1, pp.84-89, 2019
HANOĞLU, L. Et Al. (2019) . "FDG-PET scanning shows distributed changes in cortical activity associated with visual hallucinations in eye disease." Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.19, no.1, pp.84-89.
@article{article, author={Lütfü HANOĞLU Et Al. }, title={FDG-PET scanning shows distributed changes in cortical activity associated with visual hallucinations in eye disease}, journal={Endocrine, Metabolic and Immune Disorders - Drug Targets}, year=2019, pages={84-89} }